Thomas Appio - Mar 2, 2022 Form 4 Insider Report for Bausch Health Companies Inc. (BHC)

Role
CEO, Pharma Business
Signature
/s/ Debra E. Levin, attorney-in-fact for Thomas Appio
Stock symbol
BHC
Transactions as of
Mar 2, 2022
Transactions value $
$0
Form type
4
Date filed
3/4/2022, 03:50 PM
Previous filing
Mar 2, 2022
Next filing
Mar 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BHC Common Shares, No Par Value Award $0 +153K +46.53% $0.00 481K Mar 2, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BHC Non-Qualified Stock Options (right to purchase) Award $0 +565K $0.00 565K Mar 2, 2022 Common Shares, No Par Value 565K $24.17 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc.
F2 The options vest in equal installments on each of the first three anniversaries of the date of grant.